Using a continuous glucose monitor to help young adults manage type 2 diabetes.
CAPAZ-2D: Continuous Glucose Monitoring to Augment and Personalize Self-Management of Type 2 Diabetes in Hispanic/Latinx Young Adults
This 30-day program gives young adults with type 2 diabetes a wearable continuous glucose monitor to try and see if real-time glucose data helps them notice patterns and manage their blood sugar and daily habits.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 45 Years |
| Sex | All |
| Sponsor | San Diego State University Academic / other |
| Locations | 1 site (San Diego, California) |
| Trial ID | NCT07065721 on ClinicalTrials.gov |
What this trial studies
This community-engaged, mixed-methods pilot enrolls young adults (ages 18-45) with recent-onset type 2 diabetes to wear a continuous glucose monitor (CGM) for 30 days. The study collects quantitative data from the CGM and linked behavioral trackers (for example, step counts and dietary logs) alongside surveys of self-management behaviors. After the wear period, researchers conduct qualitative interviews to identify barriers and facilitators to CGM use and participants' changes in awareness of glucose patterns. Findings will inform the design of a CGM-based self-management intervention tailored to young adults.
Who should consider this trial
Good fit: Ideal candidates are 18–45 years old, diagnosed with type 2 diabetes within the past five years, have no prior wearable CGM experience, own a compatible smartphone, and are fluent in English or Spanish.
Not a fit: People with long-standing diabetes beyond five years, prior CGM experience, no compatible smartphone, pregnancy or recent postpartum status, or severe mental illness are unlikely to be eligible or to benefit from this pilot.
Why it matters
Potential benefit: If successful, this approach could help young adults better recognize glucose patterns, improve daily diabetes self-care, and reduce average blood glucose levels.
How similar studies have performed: Previous studies in adults with type 2 diabetes have shown CGMs can improve glycemic awareness and some outcomes, but using CGMs specifically in young adults with integrated behavioral data and qualitative input is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * adult 18-45 years of age * diagnosis of type 2 diabetes in the last 5 years, as evidenced in the electronic medical record * no prior use or experience with wearable CGMs * possession of a smart phone that is compatible with Dexcom CGM sensors (nearly all smartphones are compatible) and willing to download and utilize the Dexcom CGM app * fluency in English or Spanish Exclusion Criteria: * severe mental illness (e.g., psychosis, suicidal ideation); * pregnancy or \<6 months postpartum
Where this trial is running
San Diego, California
- Scripps Health — San Diego, California, United States (Recruiting)
Study contacts
- Principal investigator: Jessica L McCurley, PhD MPH — San Diego State University
- Study coordinator: Jessica L McCurley, PhD, MPH
- Email: jlmccurley@sdsu.edu
- Phone: 619-594-2132
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.